FDA limits use of Janssen COVID-19 vaccine to certain individuals
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA approves first generic of Symbicort to treat asthma and COPD
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves treatment for wider range of patients with heart failure
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes.
EMA: Human medicines highlights of 2021
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA takes key action by approving second COVID-19 vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA authorizes first oral antiviral for treatment of COVID-19
- FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
- FDA takes additional actions on the use of a booster dose for COVID-19 vaccines
- FDA awards 11 grants to clinical trials to develop new medical products for rare disease treatments
- FDA approves innovative treatment for pediatric patients with congenital athymia